Physician profile
Nathaniel Oswald
NPI 1629696794
$4,893.72
in general payments reported to CMS, 2019-2025
11 companies · $3,289 in 2025
The $3,289 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $318 · 2023: $964 · 2024: $207 · 2025: $3,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,459.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2025 | |
| Boston Scientific Corporation | $904.15 | 2022-2025 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Ams 700 |
| Coloplast Corp | $232.46 | 2022-2023 | Titan |
| Axonics, INC. | $204.01 | 2021-2022 | |
| Teleflex LLC | $159.56 | 2025 | Urolift |
| Innovation Technologies INC | $149.91 | 2023 | Irrisept |
| Olympus America INC. | $138.38 | 2023 | Itind System |
| Palette Life Sciences, INC. | $33.04 | 2022 | |
| Cook Medical LLC | $28.34 | 2024 | Ncircle |
| Alnylam Pharmaceuticals INC. | $25.93 | 2024 | Oxlumo |
| Procept Biorobotics Corporation | $17.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Oswald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.